Sitaxsentan (Leo Pharma)

N/A

Report date: 2024/02/22 16:34:42
NME

Base Information

Drug NameSitaxsentan (Leo Pharma)
Drug Alias NamePAT-S03TMB-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonists
TargetsEndothelin receptor type A
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPatagonia Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPatagonia Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsScleroderma, Systemic

Other Information

ATC CodeN/A
Related LinksN/A